Literature DB >> 29708141

Inequivalence of non-aggressiveness in clinically diagnosed lung cancers and overdiagnosis in lung cancer screening trials.

Jerome M Reich1, Jong S Kim2.   

Abstract

Entities:  

Year:  2018        PMID： 29708141      PMCID： PMC5906275          DOI： 10.21037/jtd.2018.01.164

Source DB:  PubMed          Journal:  J Thorac Dis        ISSN： 2072-1439            Impact factor:   2.895


× No keyword cloud information.
  13 in total

Review 1.  Improved survival and higher mortality: the conundrum of lung cancer screening.

Authors:  Jerome M Reich
Journal:  Chest       Date:  2002-07       Impact factor: 9.410

2.  Diminished Disease-Free Survival After Lobectomy: Screening Implications.

Authors:  Jerome M Reich; Jong S Kim; James W Asaph
Journal:  Clin Lung Cancer       Date:  2015-03-27       Impact factor: 4.785

3.  Overdiagnosis in lung cancer: different perspectives, definitions, implications.

Authors:  Peter B Bach
Journal:  Thorax       Date:  2008-04       Impact factor: 9.139

4.  Predictors of mortality after surgical management of lung cancer in the National Cancer Database.

Authors:  Joshua E Rosen; Jacquelyn G Hancock; Anthony W Kim; Frank C Detterbeck; Daniel J Boffa
Journal:  Ann Thorac Surg       Date:  2014-10-18       Impact factor: 4.330

5.  Annual or biennial CT screening versus observation in heavy smokers: 5-year results of the MILD trial.

Authors:  Ugo Pastorino; Marta Rossi; Valentina Rosato; Alfonso Marchianò; Nicola Sverzellati; Carlo Morosi; Alessandra Fabbri; Carlotta Galeone; Eva Negri; Gabriella Sozzi; Giuseppe Pelosi; Carlo La Vecchia
Journal:  Eur J Cancer Prev       Date:  2012-05       Impact factor: 2.497

6.  Early Lung Cancer Action Project: overall design and findings from baseline screening.

Authors:  C I Henschke; D I McCauley; D F Yankelevitz; D P Naidich; G McGuinness; O S Miettinen; D M Libby; M W Pasmantier; J Koizumi; N K Altorki; J P Smith
Journal:  Lancet       Date:  1999-07-10       Impact factor: 79.321

7.  Overdiagnosis in low-dose computed tomography screening for lung cancer.

Authors:  Edward F Patz; Paul Pinsky; Constantine Gatsonis; Jorean D Sicks; Barnett S Kramer; Martin C Tammemägi; Caroline Chiles; William C Black; Denise R Aberle
Journal:  JAMA Intern Med       Date:  2014-02-01       Impact factor: 21.873

8.  Long-Term Follow-up Results of the DANTE Trial, a Randomized Study of Lung Cancer Screening with Spiral Computed Tomography.

Authors:  Maurizio Infante; Silvio Cavuto; Fabio Romano Lutman; Eliseo Passera; Maurizio Chiarenza; Giuseppe Chiesa; Giorgio Brambilla; Enzo Angeli; Giuseppe Aranzulla; Arturo Chiti; Marta Scorsetti; Pierina Navarria; Raffaele Cavina; Michele Ciccarelli; Massimo Roncalli; Anna Destro; Edoardo Bottoni; Emanuele Voulaz; Valentina Errico; Giorgio Ferraroli; Giovanna Finocchiaro; Luca Toschi; Armando Santoro; Marco Alloisio
Journal:  Am J Respir Crit Care Med       Date:  2015-05-15       Impact factor: 21.405

9.  Lung cancer screening: the Mayo program.

Authors:  R S Fontana; D R Sanderson; L B Woolner; W F Taylor; W E Miller; J R Muhm
Journal:  J Occup Med       Date:  1986-08

10.  Assessing the extent of non-aggressive cancer in clinically detected stage I non-small cell lung cancer.

Authors:  Minal S Kale; Keith Sigel; Grace Mhango; Juan P Wisnivesky
Journal:  Thorax       Date:  2017-10-20       Impact factor: 9.139
View more
  2 in total

1.  Erratum to inequivalence of non-aggressiveness in clinically diagnosed lung cancers and overdiagnosis in lung cancer screening trials.

Authors:  Jerome M Reich; Jong S Kim
Journal:  J Thorac Dis       Date:  2018-06       Impact factor: 2.895

2.  Peritumoral and intratumoral radiomic features predict survival outcomes among patients diagnosed in lung cancer screening.

Authors:  Jaileene Pérez-Morales; Ilke Tunali; Olya Stringfield; Steven A Eschrich; Yoganand Balagurunathan; Robert J Gillies; Matthew B Schabath
Journal:  Sci Rep       Date:  2020-06-29       Impact factor: 4.379
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.